相似文献
1
Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do.
Am J Transplant. 2017 Aug;17(8):1967-1969. doi: 10.1111/ajt.14140. Epub 2017 Apr 10.
2
Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients.
Am J Transplant. 2017 Aug;17(8):1974-1991. doi: 10.1111/ajt.14238. Epub 2017 Apr 10.
3
Risk of lip cancer after solid organ transplantation in the United States.
Am J Transplant. 2019 Jan;19(1):227-237. doi: 10.1111/ajt.15052. Epub 2018 Sep 5.
4
Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer.
Am J Transplant. 2019 Dec;19(12):3223-3232. doi: 10.1111/ajt.15495. Epub 2019 Jul 8.
5
Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward.
Am J Transplant. 2016 Apr;16(4):1094-101. doi: 10.1111/ajt.13582. Epub 2016 Jan 5.
6
Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.
Am J Transplant. 2017 Nov;17(11):2911-2921. doi: 10.1111/ajt.14310. Epub 2017 May 30.
7
A Call to Action: The Need for Improved Transplant Cancer Screening Guidelines.
Am J Transplant. 2017 Jan;17(1):9-10. doi: 10.1111/ajt.14034. Epub 2016 Oct 3.
8
Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients.
Am J Transplant. 2022 Feb;22(2):673-675. doi: 10.1111/ajt.16855. Epub 2021 Oct 5.
9
Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
Am J Transplant. 2018 Feb;18(2):453-461. doi: 10.1111/ajt.14465. Epub 2017 Sep 2.
10
Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated.
Transpl Infect Dis. 2021 Aug;23(4):e13650. doi: 10.1111/tid.13650. Epub 2021 Jul 29.
引用本文的文献
1
Survival outcomes and risk factors after lung transplantation in patients with pre-transplant malignancy: a national cohort study.
Transl Lung Cancer Res. 2025 Jul 31;14(7):2598-2610. doi: 10.21037/tlcr-2025-224. Epub 2025 Jul 28.
2
Spectrum of cancer risk in Asian American and Pacific Islander solid organ transplant recipients.
J Natl Cancer Inst. 2025 Jul 1;117(7):1456-1464. doi: 10.1093/jnci/djaf069.
3
Imaging of cystic fibrosis manifestations in the abdomen.
Abdom Radiol (NY). 2025 May;50(5):1953-1978. doi: 10.1007/s00261-024-04636-7. Epub 2024 Nov 11.
4
Pulmonary wedge resection for lung cancer developing in a single transplanted lung: a case report.
Gen Thorac Cardiovasc Surg Cases. 2024 Jan 29;3(1):2. doi: 10.1186/s44215-023-00120-8.
5
Reconstructive Surgery of the Head and Neck in Organ Transplant Recipients: A Case Report and a Review of the Literature.
J Clin Med. 2024 Aug 14;13(16):4790. doi: 10.3390/jcm13164790.
6
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.
Haematologica. 2024 Nov 1;109(11):3615-3630. doi: 10.3324/haematol.2023.284332.
7
Donor/recipient origin of lung cancer after lung transplantation by DNA short tandem repeat analysis.
Front Oncol. 2023 Sep 28;13:1225538. doi: 10.3389/fonc.2023.1225538. eCollection 2023.
8
Incidence of malignancies after lung transplantation and their effect on the outcome. 26 years' experience.
Heliyon. 2023 Sep 30;9(10):e20592. doi: 10.1016/j.heliyon.2023.e20592. eCollection 2023 Oct.
9
A Lesson of Immunosuppression in Renal Transplant: Retreat or Hold?
Yale J Biol Med. 2023 Mar 31;96(1):57-77. doi: 10.59249/XGIO3365. eCollection 2023 Mar.
10
Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period.
Cancers (Basel). 2023 Feb 20;15(4):1347. doi: 10.3390/cancers15041347.
本文引用的文献
1
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
N Engl J Med. 2016 Nov 3;375(18):1749-1755. doi: 10.1056/NEJMoa1609214.
2
Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.
Am J Transplant. 2016 Dec;16(12):3479-3489. doi: 10.1111/ajt.13862. Epub 2016 Jun 23.
3
Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.
N Engl J Med. 2016 Mar 3;374(9):896-8. doi: 10.1056/NEJMc1509268.
4
Risk of Colorectal Cancer After Solid Organ Transplantation in the United States.
Am J Transplant. 2016 Mar;16(3):960-7. doi: 10.1111/ajt.13549. Epub 2016 Jan 5.
5
Melanoma Risk and Survival among Organ Transplant Recipients.
J Invest Dermatol. 2015 Nov;135(11):2657-2665. doi: 10.1038/jid.2015.312. Epub 2015 Aug 13.
6
Evolving synergistic combinations of targeted immunotherapies to combat cancer.
Nat Rev Cancer. 2015 Aug;15(8):457-72. doi: 10.1038/nrc3973.
7
Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.
Cancer Med. 2015 Sep;4(9):1448-59. doi: 10.1002/cam4.487. Epub 2015 Jun 24.
8
Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation.
J Immunother Cancer. 2015 Jun 16;3:22. doi: 10.1186/s40425-015-0066-0. eCollection 2015.
9
Risk of hepatobiliary cancer after solid organ transplant in the United States.
Clin Gastroenterol Hepatol. 2014 Sep;12(9):1541-9.e3. doi: 10.1016/j.cgh.2013.12.018. Epub 2013 Dec 19.
10
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.
J Natl Cancer Inst. 2013 Mar 6;105(5):350-60. doi: 10.1093/jnci/djs529. Epub 2013 Jan 4.
Zotero 插件